Stay updated on DHODH Inhibitor for AML/MDS Clinical Trial
Sign up to get notified when there's something new on the DHODH Inhibitor for AML/MDS Clinical Trial page.

Latest updates to the DHODH Inhibitor for AML/MDS Clinical Trial page
- Check3 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the completed Phase 1 study of JNJ-74856665, including its eligibility criteria, treatment arms, outcomes, locations, and record dates, in place of a forbidden-access screen.SummaryDifference57%

- Check10 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAn NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov 403 error page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now renders a 403 Forbidden error, blocking access to the study record. The visible content is an error page rather than the study details.SummaryDifference18%

- Check59 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0, indicating a newer platform version.SummaryDifference0.0%

Stay in the know with updates to DHODH Inhibitor for AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DHODH Inhibitor for AML/MDS Clinical Trial page.